Jewell Christopher M bought RNAC
January 2, 2024 · Form 4 insider transaction
Jewell Christopher M bought 998,000 shares of Cartesian Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
998,000
Price
$0.00
Total value
N/A
InsiderJewell Christopher M
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after998,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.